# Golden Valley Health Center

Health Center, CA
Page: https://astrelis.co/providers/health_center/A01023  
This twin: https://astrelis.co/providers/health_center/A01023.md  
CMS Certification Number (CCN): A01023  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2022 to 2022)

Filings that are not a full fiscal year: FY2022 covers 191 days. These years sit in no comparison pool.

- **Total patients (UDS) (FY2024):** 162,047. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2022):** -46.8%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 54. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 4.3%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2022):** $97.9M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2022):** +11.9%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Golden Valley Health Center, CA

Match to this profile: matched by name (method: name and state).

- FY ending 2025-03-31 (audit year 2025): each statement foots, not linked; audit as filed https://app.fac.gov/dissemination/summary/2025-03-GSAFAC-0000375481
- FY ending 2024-03-31 (audit year 2024): each statement foots, not linked; audit as filed https://app.fac.gov/dissemination/summary/2024-03-GSAFAC-0000050231
- FY ending 2023-03-31 (audit year 2023): each statement foots, not linked; audit as filed https://app.fac.gov/dissemination/summary/2023-03-GSAFAC-0000006896

| Line | FY ending 2025-03-31 | FY ending 2024-03-31 | FY ending 2023-03-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 108,867,329 [derived, p.6] | 109,055,558 [derived, p.6] | 117,746,847 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 19,520,326 [derived, p.6] | 18,624,875 [derived, p.6] | 9,432,561 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 17,064,780 [derived, p.6] | 7,942,202 [derived, p.6] | 4,760,129 [derived, p.6] |
| other current assets (Statement of financial position) | 4,070,222 [derived, p.6] | 3,122,573 [derived, p.6] | 2,206,588 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 149,522,657 [extracted, p.6] | 138,745,208 [extracted, p.6] | 134,146,125 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 87,091,838 [derived, p.6] | 78,797,025 [derived, p.6] | 75,435,713 [derived, p.6] |
| other long-term assets (Statement of financial position) | 52,093,561 [derived, p.6] | 33,877,141 [derived, p.6] | 20,975,105 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 288,708,056 [extracted, p.6] | 251,419,374 [extracted, p.6] | 230,556,943 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 24,854,890 [derived, p.6] | 22,213,861 [derived, p.6] | 23,686,179 [derived, p.6] |
| deferred revenue (Statement of financial position) | 37,950 [derived, p.6] | 37,700 [derived, p.6] | absent (not printed, or not read) |
| current debt and leases (Statement of financial position) | 5,331,207 [derived, p.6] | 5,149,690 [derived, p.6] | 4,522,109 [derived, p.6] |
| other current liabilities (Statement of financial position) | 2,307,062 [derived, p.6] | 10,816,554 [derived, p.6] | 162,685 [derived, p.6] |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 32,531,109 [extracted, p.6] | 38,217,805 [extracted, p.6] | 28,370,973 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 58,258,069 [derived, p.6] | 43,842,761 [derived, p.6] | 47,175,148 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | 3,480,340 [derived, p.6] |
| TOTAL LIABILITIES (Statement of financial position) | 90,789,178 [extracted, p.6] | 82,060,566 [extracted, p.6] | 79,026,461 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 192,978,133 [derived, p.6] | 165,581,273 [derived, p.6] | 151,045,823 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | 1,833,667 [derived, p.6] | 1,826,095 [derived, p.6] | 548,446 [derived, p.6] |
| TOTAL NET ASSETS (Statement of financial position) | 194,811,800 [extracted, p.6] | 167,407,368 [extracted, p.6] | 151,594,269 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 219,580,360 [derived, p.7] | 175,476,921 [derived, p.7] | 158,748,074 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | 8,489,303 [derived, p.7] | 9,561,406 [derived, p.7] | 4,989,488 [derived, p.7] |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 18,721,564 [derived, p.7] | 17,563,042 [derived, p.7] | 28,345,061 [derived, p.7] |
| contributions (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other revenue (Statement of activities) | 15,593,241 [derived, p.7] | 7,209,319 [derived, p.7] | 2,853,378 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 262,384,468 [extracted, p.7] | 209,810,688 [extracted, p.7] | 194,936,001 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 126,390,166 [derived, p.7] | 115,289,618 [derived, p.7] | 106,096,598 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 21,766,626 [derived, p.7] | 15,897,783 [derived, p.7] | 9,156,319 [derived, p.7] |
| purchased and professional services (Statement of activities) | 41,909,793 [derived, p.7] | 28,375,388 [derived, p.7] | 23,948,630 [derived, p.7] |
| occupancy (Statement of activities) | 7,341,597 [derived, p.7] | 6,592,596 [derived, p.7] | 6,054,067 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 7,190,300 [derived, p.7] | 5,881,631 [derived, p.7] | 5,556,493 [derived, p.7] |
| interest (Statement of activities) | 1,296,184 [derived, p.7] | 1,241,867 [derived, p.7] | 1,366,169 [derived, p.7] |
| other expenses (Statement of activities) | 27,937,304 [derived, p.7] | 19,981,128 [derived, p.7] | 12,877,309 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 233,831,970 [extracted, p.7] | 193,260,011 [extracted, p.7] | 165,055,585 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | 28,552,498 [extracted, p.7] | 16,550,677 [extracted, p.7] | 29,880,416 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | 7,572 [derived, p.7] | 1,277,649 [derived, p.7] | -13,325 [derived, p.7] |
| CHANGE IN NET ASSETS (Statement of activities) | 28,560,070 [extracted, p.7] | 17,828,326 [extracted, p.7] | 29,867,091 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 169,358,808 [extracted, p.7] | 151,530,482 [extracted, p.7] | 121,663,391 [extracted, p.7] |
| net assets, end (Statement of activities) | 197,918,878 [extracted, p.7] | 169,358,808 [extracted, p.7] | 151,530,482 [extracted, p.7] |

| Ratio | FY ending 2025-03-31 | FY ending 2024-03-31 | FY ending 2023-03-31 |
|---|---:|---:|---:|
| Days cash on hand | 175 days [plausible] | 213 days [plausible] | 269 days [plausible] |
| Current ratio | 4.60x [plausible] | 3.63x [plausible] | 4.73x [plausible] |
| Operating margin | 10.9% [plausible] | 7.9% [plausible] | 15.3% [plausible] |
| Total margin | 10.9% [plausible] | 8.5% [plausible] | 15.3% [plausible] |
| Patient revenue share | 83.7% [plausible] | 83.6% [plausible] | 81.4% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 54.1% [plausible] | 59.7% [plausible] | 64.3% [plausible] |
| Days in patient receivables | 32 days [plausible] | 39 days [plausible] | 22 days [plausible] |
| Debt to net assets | 0.33x [plausible] | 0.29x [plausible] | 0.34x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Golden Valley Health Center; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Golden Valley Health Center", https://astrelis.co/providers/health_center/A01023, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.